Related Experiment Video
Updated: Aug 31, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Rheumatologic associations of microscopic colitis: A narrative review
Christopher Le1, Noam Zeffren1, Neil Kramer2,3
1Department of Medicine, Bayonne Medical Center, CarePoint Health, Bayonne, NJ, USA.
Abstract:
Extraintestinal manifestations (EIMs) are frequent complications of the classical inflammatory bowel diseases, Crohn's disease and ulcerative colitis. However, in addition to the classical diseases, there is a spectrum of conditions, often termed 'microscopic colitis' (MC), in which EIMs are less well described. Our objective was to review the literature regarding the EIMs complicating MC and describe their association with systemic autoimmune rheumatic diseases. A comprehensive search and review of peer-reviewed English-language and international journals and reports was completed based on key terms, including 'microscopic colitis', 'lymphocytic colitis', 'collagenous colitis', 'inflammatory bowel disease', and 'extraintestinal manifestations', and the specific disease associations utilizing the PubMed Central database and MEDLINE. A broad spectrum of rheumatologic manifestations has been reported in patients with MC. The identification of rheumatoid arthritis and limited scleroderma as comorbidities with MC was noteworthy. Inflammatory arthropathy was frequently seen in MC, usually preceding or occurring in conjunction with the onset of gastrointestinal symptoms. A variety of presentations of associated arthritis were reported: migratory, symmetric or asymmetric, peripheral or axial, oligoarticular or polyarticular, and erosive or non-erosive. There was a high incidence of autoantibodies in these patients, supporting a potential autoimmune association. On the basis of these anecdotal reports, we would suggest the development of a clinical registry to help define the incidence of EIMs and systemic autoimmune rheumatic diseases among MC patients to help elucidate shared predispositions, pathogenic mechanisms, and therapeutic opportunities.
Insights
Extraintestinal manifestations (EIMs) are common in microscopic colitis (MC). This review highlights rheumatologic conditions like rheumatoid arthritis and scleroderma as frequent comorbidities in MC patients, suggesting shared autoimmune links.
Area of Science:
- Gastroenterology and Rheumatology
- Autoimmune Diseases
- Inflammatory Bowel Disease Spectrum
Background:
- Extraintestinal manifestations (EIMs) are well-documented in Crohn's disease and ulcerative colitis.
- EIMs in microscopic colitis (MC), including lymphocytic colitis and collagenous colitis, are less understood.
- This review focuses on rheumatologic EIMs associated with MC.
Approach:
- Comprehensive literature review of peer-reviewed journals and reports.
- Searched PubMed Central and MEDLINE using keywords: 'microscopic colitis', 'lymphocytic colitis', 'collagenous colitis', 'inflammatory bowel disease', 'extraintestinal manifestations', and specific disease associations.
- Analyzed reported rheumatologic manifestations and their association with MC.
Key Points:
- A wide range of rheumatologic conditions present in MC patients.
- Rheumatoid arthritis and limited scleroderma identified as notable comorbidities.
- Inflammatory arthropathy frequently precedes or coincides with MC onset, with diverse presentations.
- High incidence of autoantibodies suggests a potential autoimmune link.
Conclusions:
- MC is associated with a broad spectrum of rheumatologic manifestations.
- Further research, including a clinical registry, is needed to define EIM incidence and autoimmune rheumatic disease associations in MC.
- Understanding shared predispositions and pathogenic mechanisms may reveal therapeutic opportunities.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

